endpoints.studio Open in urlscan Pro
44.205.53.125  Public Scan

Form analysis
0 forms found in the DOM

Text Content

 * Products
   * Email: News Sponsorships
   * Email: Blasts
   * Web Advertising
   * Featured Sponsored Post
   * Pharma sponsored post
   * Webinars
   * Events
   * Endpoints Studio
   * Editorial Sponsorships
 * Calendar
 * Audience
 * Events
   
 * Contact


THE BIOPHARMA WORLD IS HERE

Endpoints’ industry-leading content draws a quality audience and high levels of
engagement. Let’s connect your message with these top biopharma players using
data-informed advertising to achieve your goals.

Contact us




ABOUT ENDPOINTS NEWS

Endpoints News was founded in 2016 by John Carroll and Arsalan Arif to deliver
the best news product in biopharma and become an essential read for industry
leaders across the globe. Thanks to an ambitious team of journalists across the
US, Europe and Asia and support from advertising partners, we're now read by
thousands of innovative biotechs and every top 50 pharmaceutical company in the
world. As a member of the Financial Times family, we're backed by the most
respected global brand in business journalism and committed to providing
advertisers with innovative ways to engage our growing audience of biopharma and
healthcare executives across the globe.


OUR PLATFORMS DRAW

170K+
daily email subscribers
700K+
unique monthly visitors
3.3M+
average monthly page views
87K+
event registrations in 2022


HOW YOU BENEFIT

SMART CONTENT

Deliver your unique point of view in the clear, concise style readers expect
from Endpoints News with one of our in-house Studio productions on
top-performing topics.

EXCLUSIVE INSIGHTS

Endpoints Studio offers a competitive opportunity to receive detailed insights
about who is viewing and engaging with our news reports and our sponsored
campaigns.

PRIME AUDIENCE

Reach a steadily growing, highly engaged audience that trusts Endpoints News as
the most essential source of industry news and analysis.

CAMPAIGN OPTIMIZATION

Our Studio team uses first-party data and expertise to guide clients with
creative and promotion best practices that optimize results across our
advertising products and event productions.


WHO WE'RE HELPING

Don’t just take it from us. Here’s a sampling of what our partners have had to
say about running a campaign across the Endpoints network.


MARKETING PROFESSIONAL AT A GLOBAL HEALTHCARE COMMERCIALIZATION CONSULTANCY

"We're very pleased with the performance of this [FSP] placement – in part
achieved by your team’s recommendations in the development process to optimise
our headlines. I also appreciate the detail provided delving into performance of
each native link and the benchmarks against your average metrics."


MANAGING PARTNER AT SCITARIS

"We’ve already had an email asking for a meeting based on our ad in the Early
Edition report – just getting a single project conversion would make it a good
ROI for us!"


SR. MARKETING & COMMUNICATIONS SPECIALIST AT METAGENOMI

"We were so very pleased with this piece and grateful to the Endpoints team for
the diligent Studio FSP write-up that so tactfully communicates our complex
science. Thank you for the thoughtful article and we hope to partner with you
again in the future!"


CO-FOUNDER AT GENE THERAPY CDMO

"We continue to advertise with Endpoints because they have an engaged,
dedicated, and growing biotech readership. This readership is so critical to get
in front of for generating awareness for new companies entering the biotech
space. Our ads have continuously delivered high impressions and valuable leads –
critical to our mission of establishing ourselves as a large player in the
industry."


MANAGING PARTNER AT SCITARIS

"We’ve already had an email asking for a meeting based on our ad in the Early
Edition report – just getting a single project conversion would make it a good
ROI for us!"


SR. MARKETING & COMMUNICATIONS SPECIALIST AT METAGENONMI

"We were so very pleased with this piece and grateful to the Endpoints team for
the diligent Studio FSP write-up that so tactfully communicates our complex
science. Thank you for the thoughtful article and we hope to partner with you
again in the future!"


CO-FOUNDER AT SCITARIS

"We also just looked at our website traffic, which increased by 1000% during the
Endpoints News week. Naturally, we are super happy with the collaboration and
results. In fact, we have generated a number of very interesting leads already."


CO-FOUNDER AT GENE THERAPY CDMO

"We continue to advertise with Endpoints because they have an engaged,
dedicated, and growing biotech readership. This readership is so critical to get
in front of for generating awareness for new companies entering the biotech
space. Our ads have continuously delivered high impressions and valuable leads –
critical to our mission of establishing ourselves as a large player in the
industry."


MARKETING MANAGER AT NOVOTECH

"We were thrilled to see this result from our webinar broadcast! A fantastic new
record and bar set now. Thanks to the Endpoints Studio team for your help in
making this such a success!"


MARKETING PROFESSIONAL AT A GLOBAL HEALTHCARE COMMERCIALIZATION CONSULTANCY

"We're very pleased with the performance of this [FSP] placement – in part
achieved by your team’s recommendations in the development process to optimise
our headlines. I also appreciate the detail provided delving into performance of
each native link and the benchmarks against your average metrics."


MANAGING PARTNER AT SCITARIS

"We’ve already had an email asking for a meeting based on our ad in the Early
Edition report – just getting a single project conversion would make it a good
ROI for us!"


SR. MARKETING & COMMUNICATIONS SPECIALIST AT METAGENOMI

"We were so very pleased with this piece and grateful to the Endpoints team for
the diligent Studio FSP write-up that so tactfully communicates our complex
science. Thank you for the thoughtful article and we hope to partner with you
again in the future!"


CO-FOUNDER AT GENE THERAPY CDMO

"We continue to advertise with Endpoints because they have an engaged,
dedicated, and growing biotech readership. This readership is so critical to get
in front of for generating awareness for new companies entering the biotech
space. Our ads have continuously delivered high impressions and valuable leads –
critical to our mission of establishing ourselves as a large player in the
industry."


MANAGING PARTNER AT SCITARIS

"We’ve already had an email asking for a meeting based on our ad in the Early
Edition report – just getting a single project conversion would make it a good
ROI for us!"


SR. MARKETING & COMMUNICATIONS SPECIALIST AT METAGENONMI

"We were so very pleased with this piece and grateful to the Endpoints team for
the diligent Studio FSP write-up that so tactfully communicates our complex
science. Thank you for the thoughtful article and we hope to partner with you
again in the future!"


CO-FOUNDER AT SCITARIS

"We also just looked at our website traffic, which increased by 1000% during the
Endpoints News week. Naturally, we are super happy with the collaboration and
results. In fact, we have generated a number of very interesting leads already."


CO-FOUNDER AT GENE THERAPY CDMO

"We continue to advertise with Endpoints because they have an engaged,
dedicated, and growing biotech readership. This readership is so critical to get
in front of for generating awareness for new companies entering the biotech
space. Our ads have continuously delivered high impressions and valuable leads –
critical to our mission of establishing ourselves as a large player in the
industry."


MARKETING MANAGER AT NOVOTECH

"We were thrilled to see this result from our webinar broadcast! A fantastic new
record and bar set now. Thanks to the Endpoints Studio team for your help in
making this such a success!"


MARKETING PROFESSIONAL AT A GLOBAL HEALTHCARE COMMERCIALIZATION CONSULTANCY

"We're very pleased with the performance of this [FSP] placement – in part
achieved by your team’s recommendations in the development process to optimise
our headlines. I also appreciate the detail provided delving into performance of
each native link and the benchmarks against your average metrics."


MANAGING PARTNER AT SCITARIS

"We’ve already had an email asking for a meeting based on our ad in the Early
Edition report – just getting a single project conversion would make it a good
ROI for us!"


SR. MARKETING & COMMUNICATIONS SPECIALIST AT METAGENOMI

"We were so very pleased with this piece and grateful to the Endpoints team for
the diligent Studio FSP write-up that so tactfully communicates our complex
science. Thank you for the thoughtful article and we hope to partner with you
again in the future!"

×


GET STARTED

Connect with us to request a media kit and learn more about rates and
availability.

First name
Last name
Email
Company
Job title
Phone Number (optional)
How can we help you?
Submit
Julie Notario
Executive Director, Brand Partnerships, Endpoints News

Melissa Nazzaro
Executive Director, Brand Partnerships, Endpoints News

Kari Abitbol
Director, Client Success - Endpoints Studio

×


THANK YOU!

Your message has been successfully submitted.

close


GET STARTED

Connect with us to request a media kit and learn more about rates and
availability.

First name
Last name
Email
Company
Job title
Phone Number (optional)
How can we help you?
Submit
Julie Notario
Executive Director, Brand Partnerships, Endpoints News

Melissa Nazzaro
Executive Director, Brand Partnerships, Endpoints News


© Endpoints Company 2023